In contrast, there are safety concerns that dietary carnitine may accelerate atherosclerosis via gut microbiota metabolites [16]
The ATTAIN program for obesity includes ATTAIN-1 (NCT05869903, completed), ATTAIN-2 (NCT05872620, completed), ATTAIN-3 (completed), and ATTAIN-MAINTAIN (completed)
Constipation management Semaglutide constipation responds well to a three-pronged approach: Fiber: Increase intake to 25 to 30 grams daily
To allow access for those without insurance coverage, manufacturers have introduced direct-to-consumer pharmacy programs offering GLP1 medications at a reduced cash price, but affordability remains a challenge for many, while the pricing is lower than typical annual costs paid by insurers
#nasaldelivery #GenericInnovation #OffPatent #Semaglutide #Tirzepatide #Nasal #Inhalation #obesity #weighmanagement #Diabetes To view or add a comment, sign in Every Mechanism Has a Safety Story The more I study LDL-lowering drugs, the more I realize each one has its own safety story
less research for telogen effluvium specifically, but biological plausibility is strong